Quantcast

Latest aplastic anemia Stories

2008-08-21 12:01:28

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S. Food & Drug Administration (FDA) has expanded the label for VIDAZA (azacitidine) to include data from the AZA-001 trial, which found that Vidaza is the only agent that extends survival in MDS (myelodysplastic syndromes) patients. Vidaza was also shown to delay progression to acute myelogenous leukemia (AML) in patients with MDS. Roughly 30 percent of patients diagnosed with...

2008-07-01 15:00:54

WOODCLIFF LAKE, N.J., July 1, 2008 /PRNewswire/ -- Eisai Corporation of North America today announced the preliminary efficacy data from a trial initiated in 2002 comparing Dacogen(R) (decitabine) to Best Supportive Care (BSC) in elderly patients with myelodysplastic syndromes (MDS). The data did not demonstrate a statistically significant advantage of Dacogen treatment on median overall survival. However, response rates were similar to those observed in other clinical trials of Dacogen in...

2008-07-01 09:01:12

DUBLIN, Calif., July 1 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today commented on the preliminary efficacy data from a trial, initiated in 2002, comparing Dacogen(R) (decitabine) for Injection to best supportive care (BSC) in elderly patients with myelodysplastic syndromes (MDS). The data did not demonstrate a statistically significant...

2008-06-16 09:01:18

Alexion Pharmaceuticals has announced that Soliris therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal nocturnal hemoglobinuria, independent of improvements in anemia. In clinical trials with Soliris, paroxysmal nocturnal hemoglobinuria (PNH) patients experienced a substantial improvement in PNH-related fatigue independent of changes in their anemia. This improvement was larger than the improvement in fatigue reported in a separate...

2008-06-15 03:00:06

CHESHIRE, Conn., June 15 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) independent of improvements in anemia, according to data presented today at the European Hematology Association (EHA) 13th Congress in Copenhagen (abstract number 0903). These data suggest that fatigue experienced by patients with PNH is related directly to hemolysis -- the red...

2008-04-30 03:00:10

By Coyer, Sharon M Lash, Ayhan Aytekin Anemia is a decrease in erythrocyte mass or amount of hemoglobin from impaired production of erythrocytes, blood loss, or increased erythocyte destruction. The pathophysiology, clinical manifestations, and selected pathologies of anemia and their implications for nursing practice are reviewed. As many as 4 million Americans have anemia; women younger than age 65 have six times more anemia than men. Anemia is increasingly a health problem for older...

2006-02-01 00:50:00

CHICAGO (Reuters) - Stem cells from the bone marrow of patients with severe cases of lupus can help reverse the course of the chronic inflammatory disease when transplanted back into the same patients, according to a study published on Tuesday. Of 50 patients who underwent the procedure, half were disease free after five years, doctors at Northwestern Memorial Hospital in Chicago said. Those involved in the study had either life-threatening or organ-threatening lupus and had exhausted all...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related